Cargando…

The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"

This commentary considers two editorial pieces, written by Hajizadeh and Edmonds, and Lewis, which address universal pharmacare in Canada. The pieces focus on the social inequities of the existing system and the challenges of successful implementation. After identifying the significant strengths of...

Descripción completa

Detalles Bibliográficos
Autor principal: Acri née Lybecker, Kristina M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kerman University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947897/
https://www.ncbi.nlm.nih.gov/pubmed/32610780
http://dx.doi.org/10.15171/ijhpm.2020.20
_version_ 1783663323183579136
author Acri née Lybecker, Kristina M. L.
author_facet Acri née Lybecker, Kristina M. L.
author_sort Acri née Lybecker, Kristina M. L.
collection PubMed
description This commentary considers two editorial pieces, written by Hajizadeh and Edmonds, and Lewis, which address universal pharmacare in Canada. The pieces focus on the social inequities of the existing system and the challenges of successful implementation. After identifying the significant strengths of both articles, this commentary then delves into the reasons why universal pharmacare may not be the solution, and identifies numerous thorny issues that will complicate the implementation of such a publicly funded program. Both discussions point to the need for caution and transparency going forward.
format Online
Article
Text
id pubmed-7947897
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Kerman University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-79478972021-03-16 The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada" Acri née Lybecker, Kristina M. L. Int J Health Policy Manag Commentary This commentary considers two editorial pieces, written by Hajizadeh and Edmonds, and Lewis, which address universal pharmacare in Canada. The pieces focus on the social inequities of the existing system and the challenges of successful implementation. After identifying the significant strengths of both articles, this commentary then delves into the reasons why universal pharmacare may not be the solution, and identifies numerous thorny issues that will complicate the implementation of such a publicly funded program. Both discussions point to the need for caution and transparency going forward. Kerman University of Medical Sciences 2020-02-15 /pmc/articles/PMC7947897/ /pubmed/32610780 http://dx.doi.org/10.15171/ijhpm.2020.20 Text en © 2021 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Acri née Lybecker, Kristina M. L.
The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"
title The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"
title_full The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"
title_fullStr The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"
title_full_unstemmed The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"
title_short The Challenges of Canadian Pharmacare Are More Complicated Than Acknowledged Comment on "Universal Pharmacare in Canada"
title_sort challenges of canadian pharmacare are more complicated than acknowledged comment on "universal pharmacare in canada"
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947897/
https://www.ncbi.nlm.nih.gov/pubmed/32610780
http://dx.doi.org/10.15171/ijhpm.2020.20
work_keys_str_mv AT acrineelybeckerkristinaml thechallengesofcanadianpharmacarearemorecomplicatedthanacknowledgedcommentonuniversalpharmacareincanada
AT acrineelybeckerkristinaml challengesofcanadianpharmacarearemorecomplicatedthanacknowledgedcommentonuniversalpharmacareincanada